Prevention Of Group A Streptococcal Disease In The Developing World: Investigating Innovative Control Strategies For Rheumatic Heart Disease And Impetigo
Funder
National Health and Medical Research Council
Funding Amount
$178,614.00
Summary
Group A streptococcal diseases, including rheumatic heart disease and impetigo, are major causes of illness globally, mostly in developing countries. This proposal is a comprehensive investigation into new ways of curbing these diseases, including using ultrasound screening for rheumatic heart disease, community wide treatment for impetigo and laboratory testing for new vaccines. The studies will be done in Fiji and will be relevant for other developing countries and for Indigenous Australians.
Group A streptococcal diseases, including rheumatic heart disease, are major causes of illness globally, mostly in developing countries. This proposal is an investigation into how best to tackle control these diseases. It focuses on 1) a novel way to detect rheumatic heart disease in its earliest phases using ultrasound, 2) using a single drug once per year to stop streptococcal skin sores by controlling scabies infestation in whole communities and 3) developing a new vaccine that is applicable ....Group A streptococcal diseases, including rheumatic heart disease, are major causes of illness globally, mostly in developing countries. This proposal is an investigation into how best to tackle control these diseases. It focuses on 1) a novel way to detect rheumatic heart disease in its earliest phases using ultrasound, 2) using a single drug once per year to stop streptococcal skin sores by controlling scabies infestation in whole communities and 3) developing a new vaccine that is applicable across all regions of the world.Read moreRead less
Investigation Of The Epidemiology And Care Of Rheumatic Heart Disease Patients In Resource Poor Settings And At Risk Populations
Funder
National Health and Medical Research Council
Funding Amount
$192,534.00
Summary
This project aims to Investigate of the impact of Rheumatic Heart Disease (RHD) patients in resource poor settings and at risk populations with a focus on the Asia Pacific region. Studies will be undertaken to contribute to the understanding of the burden of disease in the Asia Pacific; to determine the impact of RHD on young pregnant women; to evaluate complications and outcomes of RHD patients who have had heart surgery in Fiji and trial an intervention to improve clinical management.